TCL Archive Phase II Imbruvica Trial Shows 47% of MCL Patients Alive at 27-Month Median Follow-up December 26, 2014
TCL Archive NCI Proposes Three New Grant Programs In Nutrition And Research; DRCCA Board, NCAB Approval Required November 28, 1980